Arvinas (ARVN) Stock Forecast, Price Target & Predictions
ARVN Stock Forecast
Arvinas stock forecast is as follows: an average price target of $75.36 (represents a 200.84% upside from ARVN’s last price of $25.05) and a rating consensus of 'Buy', based on 13 wall street analysts offering a 1-year stock forecast.
ARVN Price Target
The average price target for Arvinas (ARVN) is $75.36 based on 1-year price targets from 13 Wall Street analysts in the past 3 months, with a price target range of $123.00 to $24.00. This represents a potential 200.84% upside from ARVN's last price of $25.05.
ARVN Analyst Ratings
According to 13 Wall Street analysts, Arvinas's rating consensus is 'Buy'. The analyst rating breakdown for ARVN stock is 0 'Strong Buy' (0.00%), 11 'Buy' (84.62%), 2 'Hold' (15.38%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Arvinas Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| May 16, 2024 | Matthew Biegler | Oppenheimer | $70.00 | $32.11 | 118.00% | 179.44% |
| Apr 12, 2024 | Andrew Fein | H.C. Wainwright | $87.00 | $37.26 | 133.49% | 247.31% |
| Apr 11, 2024 | Bradley Canino | Stifel Nicolaus | $72.00 | $38.73 | 85.90% | 187.43% |
| Dec 19, 2023 | Derek Archila | Wells Fargo | $63.00 | $37.87 | 66.36% | 151.50% |
| Oct 23, 2023 | Robert Driscoll | Wedbush | $24.00 | $14.83 | 61.83% | -4.19% |
| Jan 03, 2023 | - | Wells Fargo | $49.00 | $34.21 | 43.23% | 95.61% |
| Dec 05, 2022 | - | Citigroup | $72.00 | $41.39 | 73.96% | 187.43% |
| Nov 23, 2022 | - | Barclays | $70.00 | $40.70 | 71.99% | 179.44% |
| Nov 22, 2022 | Edward Tenthoff | Piper Sandler | $81.00 | $40.70 | 99.02% | 223.35% |
| Nov 11, 2022 | - | Morgan Stanley | $57.00 | $45.98 | 23.97% | 127.54% |
The latest Arvinas stock forecast, released on May 16, 2024 by Matthew Biegler from Oppenheimer, set a price target of $70.00, which represents a 118.00% increase from the stock price at the time of the forecast ($32.11), and a 179.44% increase from ARVN last price ($25.05).
Arvinas Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 5 |
| Avg Price Target | - | - | $63.20 |
| Last Closing Price | $25.05 | $25.05 | $25.05 |
| Upside/Downside | -100.00% | -100.00% | 152.30% |
In the current month, the average price target of Arvinas stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Arvinas's last price of $25.05. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 09, 2024 | Wedbush | Buy | Buy | Hold |
| Jul 31, 2024 | Wells Fargo | Buy | Buy | Hold |
| May 17, 2024 | Wells Fargo | Buy | Buy | Hold |
| May 16, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Apr 12, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Dec 19, 2023 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| Dec 06, 2023 | Jefferies | - | Buy | Upgrade |
| Nov 20, 2023 | Guggenheim | Neutral | Buy | Upgrade |
| Oct 24, 2023 | Barclays | Overweight | Overweight | Hold |
| Oct 23, 2023 | Wedbush | - | Outperform | Upgrade |
Arvinas's last stock rating was published by Wedbush on Sep 09, 2024. The company gave ARVN a "Buy" rating, the same as its previous rate.
Arvinas Financial Forecast
Arvinas Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | $-43.10M | $34.60M | $54.50M | $32.50M | $38.00M | $30.30M | - | $24.20M | $25.63M | $9.28M | $5.54M | $5.54M | $2.22M | $7.60M | $5.75M | $6.24M | $4.89M | $30.05M | $4.02M | $4.02M | $3.38M |
| Avg Forecast | $66.32M | $30.75M | $29.97M | $30.08M | $62.72M | $60.56M | $33.27M | $32.94M | $48.33M | $39.45M | $30.94M | $27.91M | $35.72M | $34.70M | $24.75M | $25.45M | $14.14M | $196.39M | $5.60M | $3.68M | $6.89M | $5.22M | $5.36M | $4.44M | $5.34M | $4.44M | $3.69M | $3.44M | $7.50M |
| High Forecast | $190.98M | $88.54M | $86.31M | $86.63M | $180.61M | $146.72M | $95.81M | $94.87M | $69.63M | $113.61M | $89.10M | $80.37M | $102.86M | $99.93M | $24.75M | $36.35M | $20.19M | $280.44M | $8.00M | $5.26M | $9.84M | $7.46M | $7.65M | $6.34M | $7.63M | $6.33M | $5.27M | $4.91M | $9.00M |
| Low Forecast | $31.26M | $14.49M | $14.13M | $14.18M | $29.56M | $25.74M | $15.68M | $15.53M | $37.27M | $18.60M | $14.58M | $13.16M | $16.84M | $16.36M | $24.75M | $18.17M | $10.10M | $140.22M | $4.00M | $2.63M | $4.92M | $3.73M | $3.82M | $3.17M | $3.82M | $3.17M | $2.63M | $2.45M | $6.00M |
| # Analysts | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 6 | 15 |
| Surprise % | - | - | - | - | - | - | - | - | -0.89% | 0.88% | 1.76% | 1.16% | 1.06% | 0.87% | - | 0.95% | 1.81% | 0.05% | 0.99% | 1.51% | 0.32% | 1.45% | 1.07% | 1.40% | 0.92% | 6.78% | 1.09% | 1.17% | 0.45% |
Arvinas's average Quarter revenue forecast for Mar 24 based on 6 analysts is $32.94M, with a low forecast of $15.53M, and a high forecast of $94.87M. ARVN's average Quarter revenue forecast represents a -176.43% decrease compared to the company's last Quarter revenue of $-43.10M (Dec 23).
Arvinas EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 6 | 15 |
| EBITDA | - | - | - | - | - | - | - | - | $-165.30M | $-73.90M | $-74.60M | $-87.70M | $-75.40M | $-65.10M | - | $-57.90M | $-52.37M | $-45.23M | $-48.80M | $-39.49M | $-40.24M | $-29.71M | $-24.35M | $-20.94M | $-20.31M | $-17.04M | $-16.65M | $-13.95M | $-13.18M |
| Avg Forecast | $-66.32M | $-30.75M | $-29.97M | $-30.08M | $-62.72M | $-60.56M | $-33.27M | $-43.84M | $-48.33M | $-39.45M | $-30.94M | $-39.86M | $-35.72M | $-88.68M | $-24.75M | $-36.23M | $-38.45M | $-94.84M | $-37.76M | $-38.53M | $-6.89M | $-24.91M | $-21.87M | $-22.33M | $-5.34M | $-14.08M | $-10.40M | $-13.95M | $-29.31M |
| High Forecast | $-31.26M | $-14.49M | $-14.13M | $-14.18M | $-29.56M | $-25.74M | $-15.68M | $-35.07M | $-37.27M | $-18.60M | $-14.58M | $-31.89M | $-16.84M | $-70.94M | $-24.75M | $-28.99M | $-30.76M | $-75.87M | $-30.21M | $-30.83M | $-4.92M | $-19.93M | $-17.50M | $-17.86M | $-3.82M | $-11.26M | $-8.32M | $-11.16M | $-23.44M |
| Low Forecast | $-190.98M | $-88.54M | $-86.31M | $-86.63M | $-180.61M | $-146.72M | $-95.81M | $-52.61M | $-69.63M | $-113.61M | $-89.10M | $-47.83M | $-102.86M | $-106.41M | $-24.75M | $-43.48M | $-46.14M | $-113.81M | $-45.32M | $-46.24M | $-9.84M | $-29.89M | $-26.25M | $-26.80M | $-7.63M | $-16.90M | $-12.48M | $-16.75M | $-35.17M |
| Surprise % | - | - | - | - | - | - | - | - | 3.42% | 1.87% | 2.41% | 2.20% | 2.11% | 0.73% | - | 1.60% | 1.36% | 0.48% | 1.29% | 1.03% | 5.84% | 1.19% | 1.11% | 0.94% | 3.80% | 1.21% | 1.60% | 1.00% | 0.45% |
undefined analysts predict ARVN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Arvinas's previous annual EBITDA (undefined) of $NaN.
Arvinas Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 6 | 15 |
| Net Income | - | - | - | - | - | - | - | - | $-154.80M | $-64.00M | $-66.60M | $-80.80M | $-79.90M | $-66.20M | - | $-63.40M | $-53.06M | $-46.75M | $-50.29M | $-40.96M | $-41.55M | $-30.82M | $-25.23M | $-21.74M | $-21.05M | $-17.68M | $-17.16M | $-14.40M | $-13.39M |
| Avg Forecast | $-78.99M | $-100.87M | $-99.94M | $-94.37M | $-69.74M | $-68.06M | $-77.97M | $-49.99M | $-85.47M | $-113.80M | $-118.62M | $-45.45M | $-84.42M | $-91.66M | $-78.52M | $-41.32M | $-38.91M | $-98.03M | $-38.91M | $-39.97M | $-46.31M | $-25.83M | $-22.66M | $-23.19M | $-33.09M | $-14.60M | $-10.73M | $-14.40M | $-29.76M |
| High Forecast | $-24.71M | $-31.55M | $-31.26M | $-29.52M | $-21.81M | $-8.51M | $-24.39M | $-39.99M | $-48.20M | $-35.60M | $-37.10M | $-36.36M | $-26.41M | $-73.33M | $-78.52M | $-33.05M | $-31.13M | $-78.42M | $-31.13M | $-31.97M | $-29.09M | $-20.67M | $-18.13M | $-18.55M | $-20.79M | $-11.68M | $-8.58M | $-11.52M | $-23.81M |
| Low Forecast | $-272.01M | $-347.35M | $-344.17M | $-324.98M | $-240.15M | $-106.73M | $-268.51M | $-59.99M | $-127.89M | $-391.91M | $-408.50M | $-54.54M | $-290.73M | $-109.99M | $-78.52M | $-49.58M | $-46.69M | $-117.64M | $-46.70M | $-47.96M | $-72.07M | $-31.00M | $-27.19M | $-27.83M | $-51.51M | $-17.52M | $-12.87M | $-17.29M | $-35.71M |
| Surprise % | - | - | - | - | - | - | - | - | 1.81% | 0.56% | 0.56% | 1.78% | 0.95% | 0.72% | - | 1.53% | 1.36% | 0.48% | 1.29% | 1.03% | 0.90% | 1.19% | 1.11% | 0.94% | 0.64% | 1.21% | 1.60% | 1.00% | 0.45% |
Arvinas's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ARVN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Arvinas SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 6 | 15 |
| SG&A | - | - | - | - | - | - | - | - | $27.00M | $22.60M | $25.70M | $24.90M | $15.10M | $20.00M | - | $20.20M | $18.26M | $16.01M | $14.41M | $12.32M | $12.23M | $9.33M | $8.82M | $7.93M | $7.27M | $7.96M | $6.44M | $5.64M | $4.28M |
| Avg Forecast | $73.08M | $33.88M | $33.03M | $33.15M | $69.11M | $66.73M | $36.66M | $15.93M | $53.26M | $43.47M | $34.09M | $14.48M | $39.36M | $31.39M | $27.27M | $13.16M | $13.40M | $33.58M | $6.17M | $4.06M | $7.59M | $5.75M | $5.90M | $4.90M | $5.89M | $4.89M | $4.06M | $3.79M | $8.27M |
| High Forecast | $210.44M | $97.56M | $95.10M | $95.46M | $199.01M | $161.67M | $105.57M | $19.11M | $76.72M | $125.19M | $98.18M | $17.38M | $113.34M | $37.67M | $27.27M | $15.80M | $16.09M | $40.29M | $8.81M | $5.79M | $10.84M | $8.22M | $8.43M | $6.99M | $8.41M | $6.98M | $5.80M | $5.41M | $9.92M |
| Low Forecast | $34.45M | $15.97M | $15.57M | $15.63M | $32.58M | $28.36M | $17.28M | $12.74M | $41.06M | $20.49M | $16.07M | $11.58M | $18.55M | $25.11M | $27.27M | $10.53M | $10.72M | $26.86M | $4.41M | $2.90M | $5.42M | $4.11M | $4.21M | $3.50M | $4.20M | $3.49M | $2.90M | $2.70M | $6.61M |
| Surprise % | - | - | - | - | - | - | - | - | 0.51% | 0.52% | 0.75% | 1.72% | 0.38% | 0.64% | - | 1.53% | 1.36% | 0.48% | 2.34% | 3.04% | 1.61% | 1.62% | 1.49% | 1.62% | 1.23% | 1.63% | 1.59% | 1.49% | 0.52% |
Arvinas's average Quarter SG&A projection for Mar 24 is $15.93M, based on 6 Wall Street analysts, with a range of $12.74M to $19.11M. The forecast indicates a -41.01% fall compared to ARVN last annual SG&A of $27.00M (Dec 23).
Arvinas EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 8 | 5 | 4 | 4 | 8 | 11 | 5 | 6 | 12 | 9 | 9 | 9 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 | 10 | 10 | 10 | 10 | 6 | 6 | 6 | 6 | 15 |
| EPS | - | - | - | - | - | - | - | - | $-2.53 | $-1.18 | $-1.25 | $-1.52 | $-1.50 | $-1.24 | - | $-1.20 | $-1.00 | $-0.94 | $-1.03 | $-0.84 | $-0.99 | $-0.79 | $-0.65 | $-0.56 | $-0.56 | $-0.54 | $-0.55 | $-0.46 | $-6.66 |
| Avg Forecast | $-1.10 | $-1.40 | $-1.39 | $-1.31 | $-0.97 | $-0.95 | $-1.08 | $-1.42 | $-1.19 | $-1.58 | $-1.65 | $-1.54 | $-1.17 | $-1.16 | $-1.10 | $-0.93 | $-0.79 | $2.12 | $-0.86 | $-0.83 | $-0.76 | $-0.68 | $-0.59 | $-0.57 | $-0.54 | $-0.46 | $-0.40 | $-0.46 | $-3.31 |
| High Forecast | $-0.34 | $-0.44 | $-0.43 | $-0.41 | $-0.30 | $-0.12 | $-0.34 | $-0.44 | $-0.67 | $-0.50 | $-0.52 | $-0.48 | $-0.37 | $-0.36 | $-1.10 | $-0.59 | $-0.49 | $3.30 | $-0.54 | $-0.52 | $-0.48 | $-0.43 | $-0.37 | $-0.36 | $-0.34 | $-0.29 | $-0.25 | $-0.29 | $-2.65 |
| Low Forecast | $-3.78 | $-4.83 | $-4.79 | $-4.52 | $-3.34 | $-1.48 | $-3.73 | $-4.89 | $-1.78 | $-5.45 | $-5.68 | $-5.30 | $-4.04 | $-4.01 | $-1.10 | $-1.45 | $-1.23 | $1.33 | $-1.34 | $-1.30 | $-1.18 | $-1.06 | $-0.92 | $-0.88 | $-0.84 | $-0.72 | $-0.63 | $-0.72 | $-3.97 |
| Surprise % | - | - | - | - | - | - | - | - | 2.13% | 0.75% | 0.76% | 0.99% | 1.28% | 1.06% | - | 1.29% | 1.27% | -0.44% | 1.19% | 1.01% | 1.31% | 1.16% | 1.10% | 0.99% | 1.03% | 1.17% | 1.37% | 0.99% | 2.01% |
According to undefined Wall Street analysts, Arvinas's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ARVN previous annual EPS of $NaN (undefined).
Arvinas Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| IPSC | Century Therapeutics | $1.60 | $20.00 | 1150.00% | Buy |
| PLRX | Pliant Therapeutics | $12.00 | $39.71 | 230.92% | Buy |
| STTK | Shattuck Labs | $3.81 | $12.00 | 214.96% | Buy |
| ARVN | Arvinas | $25.05 | $75.36 | 200.84% | Buy |
| RLAY | Relay Therapeutics | $7.60 | $19.50 | 156.58% | Buy |
| BDTX | Black Diamond Therapeutics | $6.19 | $14.75 | 138.29% | Buy |
| STOK | Stoke Therapeutics | $14.47 | $33.75 | 133.24% | Buy |
| FHTX | Foghorn Therapeutics | $9.72 | $18.00 | 85.19% | Buy |
| RARE | Ultragenyx Pharmaceutical | $58.74 | $108.14 | 84.10% | Buy |
| CCCC | C4 Therapeutics | $6.44 | $11.33 | 75.93% | Hold |
| KURA | Kura Oncology | $20.88 | $28.67 | 37.31% | Buy |
| CRNX | Crinetics Pharmaceuticals | $53.80 | $70.14 | 30.37% | Buy |
| RVMD | Revolution Medicines, Inc. Warrant | $43.70 | $51.20 | 17.16% | Buy |
| NRIX | Nurix Therapeutics | $24.80 | $27.57 | 11.17% | Buy |
| KYMR | Kymera Therapeutics | $46.08 | $51.10 | 10.89% | Buy |
ARVN Forecast FAQ
Is Arvinas a good buy?
Yes, according to 13 Wall Street analysts, Arvinas (ARVN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 11 'Buy' recommendations, accounting for 84.62% of ARVN's total ratings.
What is ARVN's price target?
Arvinas (ARVN) average price target is $75.36 with a range of $24 to $123, implying a 200.84% from its last price of $25.05. The data is based on 13 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Arvinas stock go up soon?
According to Wall Street analysts' prediction for ARVN stock, the company can go up by 200.84% (from the last price of $25.05 to the average price target of $75.36), up by 391.02% based on the highest stock price target, and down by -4.19% based on the lowest stock price target.
Can Arvinas stock reach $40?
ARVN's average twelve months analyst stock price target of $75.36 supports the claim that Arvinas can reach $40 in the near future.
What are Arvinas's analysts' financial forecasts?
Arvinas's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $189.49M (high $518M, low $86.51M), average EBITDA is $-200M (high $-106M, low $-476M), average net income is $-266M (high $-94.702M, low $-675M), average SG&A $188.42M (high $485.37M, low $90.96M), and average EPS is $-4.421 (high $-1.205, low $-13.448). ARVN's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $157.12M (high $452.47M, low $74.06M), average EBITDA is $-157M (high $-74.062M, low $-452M), average net income is $-374M (high $-117M, low $-1.288B), average SG&A $173.13M (high $498.58M, low $81.61M), and average EPS is $-5.204 (high $-1.628, low $-17.921).
Did the ARVN's actual financial results beat the analysts' financial forecasts?
Based on Arvinas's last annual report (Dec 2023), the company's revenue was $78.5M, which missed the average analysts forecast of $146.64M by -46.47%. Apple's EBITDA was $-402M, beating the average prediction of $-159M by 153.18%. The company's net income was $-367M, beating the average estimation of $-363M by 1.09%. Apple's SG&A was $100.3M, missing the average forecast of $145.3M by -30.97%. Lastly, the company's EPS was $-6.62, beating the average prediction of $-5.961 by 11.05%. In terms of the last quarterly report (Dec 2023), Arvinas's revenue was $-43.1M, missing the average analysts' forecast of $48.33M by -189.17%. The company's EBITDA was $-165M, beating the average prediction of $-48.335M by 241.99%. Arvinas's net income was $-155M, beating the average estimation of $-85.474M by 81.11%. The company's SG&A was $27M, missing the average forecast of $53.26M by -49.31%. Lastly, the company's EPS was $-2.53, beating the average prediction of $-1.189 by 112.82%